Amarin Reports Record Fourth Quarter and Full Year 2018 Financial Results and Provides Update on Operations

Go back to Amarin Reports Record Fourth Quarter and Full Year 2018 Financial Results and Provides Update on Operations

Amarin (AMRN) Q4 'Very Strong', Seen as 'Great Tuck-In' for Big Pharma - Jefferies

February 27, 2019 12:52 PM EST

Jefferies analyst Michael Yee weighed in on Amarin Corporation (NASDAQ: AMRN) following "very strong" Q4 results as the company is working hard to file the sNDA to expand the label by 10x to a broad CV population this quarter.

Yee notes... More